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ABSTRACT
A conditional gene expression system that is
fast-acting, is tunable and achieves single-gene
specificity was recently developed for yeast. A
gene placed directly downstream of a modified
GAL1 promoter containing six Zif268 binding se-
quences (with single nucleotide spacing) was
shown to be selectively inducible in the presence
of b-estradiol, so long as cells express the artificial
transcription factor, Z3EV (a fusion of the Zif268 DNA
binding domain, the ligand binding domain of the
human estrogen receptor and viral protein 16). We
show the strength of Z3EV-responsive promoters
can be modified using straightforward design prin-
ciples. By moving Zif268 binding sites toward the
transcription start site, expression output can be
nearly doubled. Despite the reported requirement
of estrogen receptor dimerization for hormone-
dependent activation, a single binding site suffices
for target gene activation. Target gene expression
levels correlate with promoter binding site copy
number and we engineer a set of inducible
promoter chassis with different input–output char-
acteristics. Finally, the coupling between inducer
identity and gene activation is flexible: the ligand
specificity of Z3EV can be re-programmed to
respond to a non-hormone small molecule with
only five amino acid substitutions in the human
estrogen receptor domain, which may prove useful
for industrial applications.
INTRODUCTION
Numerous strategies have emerged for controlling levels
of gene expression in yeast. These include introducing se-
quences that disfavor nucleosome localization near the
transcription start site (1), varying both the afﬁnity and
number of binding sites for transcriptional activators in
the promoter (2–4) and randomization of core promoter
elements (5). Protein levels can also be greatly inﬂuenced
by the 50-UTR and 30-UTR sequences. The sequence
‘AAA’ at positions 1 ! 3 of the gene’s initial ATG
favor high protein expression, while out-of-frame AUGs
in the 50-UTR near the start codon reduce protein levels
(6). In the 30-UTR, higher A/T content upstream of the
polyadenylation site correlates with higher protein expres-
sion (7). While promoter strength and protein expression
can be tuned in a variety of ways, it is also desirable to
selectively introduce or remove selected gene products so
that the effects of gain or loss of function can be assayed
(3,8–10).
Conditional induction of gene expression has relied
heavily on placing genes under the control of nutrient-
responsive DNA sequences (11,12). Promoters responsive
to the tetracycline analog doxycycline and to hormones
such as b-estradiol, both of which are inert with respect
physiology, have also been developed (13–15). In the case
of b-estradiol, artiﬁcial transcription factors (ATFs) con-
taining a DNA binding domain, a hormone binding
domain and an activation domain are expressed in the
cell. The ATF Gal4dbd.hER.VP16 (GEV) is a fusion of
the Saccharomyces cerevisiae Gal4p DNA binding
domain, the ligand binding domain of the human
estrogen receptor (hER) and the activation domain of
viral protein 16 (VP16, from herpes simplex virus)
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(14,15). In the absence of inducer, GEV is sequestered to
the cytoplasm where, through the hER, it interacts with
the Hsp90 chaperone complex (15,16). On addition of
inducer, GEV dissociates from the Hsp90 chaperone
complex, localizes to the nucleus and activates expression
of genes placed downstream of promoters containing
Gal4p-responsive DNA elements (14,15).
The GEV system has many desirable properties. It is
fast-acting, has a graded input–output relationship with
respect to inducer concentration, activates expression in
all cells and works in diverse media formulations
(including those using 2% glucose as a carbon source)
(15,17). However, the presence of the Gal4p DNA
binding domain results in unwanted activation of many
off-target genes (as well as indirect repression of others),
resulting in defective growth at moderate-to-high levels of
inducer (15). By replacing the DNA binding domain of
GEV with others that have few-to-no binding sites in the
genome [as detailed in (3,18)], the desirable properties
of GEV can be retained while eliminating any unwanted
off-target effects. One such protein, Z3EV, is identical to
GEV, except for the DNA binding domain, which is
replaced with Zif268 (Z3 refers to the fact that Zif268
has three zinc ﬁngers, which results in 9 bp of DNA
speciﬁcity).
In this manuscript, we tested promoter design principles
and expanded the range of Z3EV functionality.
Speciﬁcally, the effects of 50-UTR sequence, binding site
copy number and binding site spacing on gene expression
were tested in Z3EV-responsive promoters. We ﬁnd that a
single binding site is enough to make a promoter Z3EV-
inducible. In promoters with multiple binding sites, inter-
binding site spacing can affect the level of induction,
especially at sub-saturating concentrations of inducer.
Whereas previously we exclusively used GAL1 promoters
modiﬁed to include Z3EV binding sites, here we test the
ability of other promoter chassis to be made inducible by
Z3EV with a high dynamic range. Finally, we show that
changing ﬁve amino acids in the hER domain is sufﬁcient
to make Z3EV completely non-responsive to b-estradiol,
but strongly responsive to a non-steroid small molecule.
MATERIALS AND METHODS
Strains, media and cloning
The parent strain used in the promoter- and ATF-charac-
terization experiments is a derivative of CEN.PK113-7 d
(19) in which URA3 was replaced by NatMX. NatMX is
ﬂanked by targeting sequences for the endonuclease
F-CphI to facilitate its removal if desired. Chemostat
and growth experiments were performed using
DBY12000, an s288c-derivative with a functional HAP1
allele (8). For batch experiments, yeast cells were cultured
in either complete synthetic medium lacking uracil
(CSM-U; 2% dextrose) or yeast extract-peptone-dextrose
medium (1% yeast extract, 2% bactopeptone and 2%
dextrose).
Transformations were performed using a standard
lithium acetate method (20). All cloning was performed
using DNA gap repair in the yeast strain CEN.PK2-1c,
a tryptophan auxotroph (MATa; ura3-52; trp1-289; leu2-
3,112; his3D 1; MAL2-8C; SUC2). Complete synthetic
medium lacking tryptophan (CSM-W; 2% dextrose) was
used as selective medium for yeast outgrowth following
transformation. Yeast transformations were miniprepped
directly from liquid cultures and transformed into
XL1-Blue cells (Agilent). Single colonies were selected
on LB-CARB (0.5% yeast extract, 1% tryptone, 0.5%
NaCl and 0.1 g/l carbenicillin) and proper assemblies
were conﬁrmed via restriction digestion and Sanger
sequencing as described previously (21). The vector used
for assembly is a derivative of the TRP1-marked yeast
shuttle vector pRS414 with the LacZ open reading frame
disrupted by a pair of linkers, referred to as 0 and 9,
between which DNA assemblies were constructed:
Linker 0=GACGGCACGGCCACGCGTTTAAACCG
CC; Linker 9=CGGTGTTTAAACCCCAGCGCCTGG
CGGG. Genomic insertions were generated via trans-
formation of two linear DNA fragments with overlap in
the URA3 marker and subsequent selection for growth on
CSM-U agar medium. Colony polymerase chain reaction
was used to conﬁrm proper insertion at the BUD9 locus.
b-estradiol (Sigma-Aldrich) and 40-40-dihydroxybenzyl
(DHB; Austin Chemical Company) were dissolved in
100% ethanol at 25mM and stored at 4C. Synthetic pro-
moters and yeast codon-optimized ATFs were synthesized
commercially (SGI-DNA, La Jolla, CA, USA). Codon-
optimized sequences were determined using Integrated
DNA Technologies’ web interface (Coralville, IA). The
ﬂuorescent reporter, GFP-Dasher, was obtained from
DNA2.0 (Menlo Park, CA, USA). Restriction enzymes
were obtained from New England Biolabs (Ipswich,
MA, USA).
Flow cytometry
For dose–response experiments, saturated overnight
cultures in CSM-U medium were diluted 1:200 in 5ml of
fresh CSM-U medium. Cells were incubated with different
levels of b-estradiol or DHB for 12h. Approximately 107
cells were harvested and re-suspended in phosphate
buffered saline supplemented with 0.1% Tween-20. Green
ﬂuorescent protein (GFP) ﬂuorescence measurements were
made with a BD FACSAria II (BD Biosciences, Sparks,
MD, USA). Mean ﬂuorescence values were obtained
from a minimum of 10 000 cells in each sample, and the
ﬂuorescence detector calibration settings maintained
constant between experiments. Positive and negative GFP
controls were used to ensure that the instrument main-
tained proper calibration and to ensure proper normaliza-
tion. For kinetic experiments, cells were allowed to grow
for 4 h before introduction of inducer. For all ﬂow
cytometry experiments, data analysis was performed in
MATLAB, as described previously (18).
Chemostat experiment
Yeast cells were cultured in a 500-ml chemostat (Sixfors,
Infors AG, Bottmingen, Switzerland) under phosphate
limitation (20mg/l). The culture was grown at 30 C,
stirred at 400 rpm, aerated with ﬁltered humidiﬁed air,
and maintained at a volume of 300ml. The growth rate
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was maintained at 0.17 h1 (culture doubling time=4.08
h). Batch growth was initiated from a 1:60 dilution of an
overnight culture (also grown in phosphate-limited
chemostat medium). Cells were grown to steady state (as
determined by optical density and cell size) before
addition of DHB.
Microarrays
RNA extraction, labeling and hybridization were per-
formed as described previously (22) with slight modiﬁca-
tions. Brieﬂy, chemostat samples (5ml) were vacuum-
ﬁltered onto 0.45 -mm nylon membranes (Millipore,
HNWP02500), placed in 2-ml locking lid tubes
(FisherBrand, 02-681-291) and ﬂash-frozen in liquid
nitrogen. Crude RNA was extracted with a standard
acid–phenol procedure and cleaned with RNeasy mini
columns (QIAGEN, Valencia, CA, USA) before mRNA
ampliﬁcation and labeling with the Agilent Quick-Amp
Labeling Kit (Part No. 5190-0424). Ampliﬁcation and
labeling were performed according to the manufacturer’s
instructions with half the volume of each reagent and
0.6 ml of Cy3 or Cy5 dye. Reference RNA was extracted
from cells harvested just before addition of DHB. Agilent
Yeast Oligo V2 microarrays (8 15 k) were hybridized for
17 h at 65C on a rotisserie at 20 rpm. Following a series of
wash steps, hybridized microarrays were scanned and raw
data were extracted with Agilent Feature Extractor
Software version 9.5.
RESULTS
For all promoter characterization experiments, a contigu-
ous string of DNA ‘parts’ replaces the entire BUD9 open
reading frame. Z3EV is constitutively expressed from the
ACT1 promoter, followed sequentially by URA3 (used as
a selection marker for genomic integration), the synthetic
promoter to be tested and GFP (Figure 1). The level of
gene expression from each promoter was measured from
three independent cultures (from three independent
colonies) via ﬂow cytometry in the absence or presence
(medium level=10 nM or high level=1 mM) of b-estra-
diol. A complete list of strains can be found in Table 1,
and the sequences of DNA parts can be found in the
Supplement. In addition to the ﬁgures that illustrate
binding site location and spacing, each promoter is
assigned a unique number (P1–P15).
Modiﬁed GAL1 promoters
Previously, we removed the three canonical Gal4p activa-
tion sequences in the GAL1 promoter and replaced them
with six Zif268 binding sites with single nucleotide spacing
(Figure 2A, P1) (3). A modiﬁed GAL1 promoter in which
ﬁve Zif628 binding sites have 9-bp spacing remains indu-
cible at both 10 nM and 1 mM b-estradiol (Figure 2A, P2),
demonstrating that there is some ﬂexibility over the exact
choice of binding site spacing.
In promoters containing six randomly dispersed binding
sites (Figure 2A, P3), or six binding sites with single nu-
cleotide spacing (Figure 2A, P4), expression in the
presence of 1 mM b-estradiol nearly doubled with respect
to our original promoter design, P1. In both P3 and P4,
the binding site closest to the start codon is 235 bp and
242 bp, respectively (100 bp upstream of the transcrip-
tion start state [TSS]). In P1 and P2, the binding site
closest to the start codon is 408 and 385 bp (250 bp
upstream of the TSS), respectively. These results demon-
strate that moving binding sites closer to the TSS of
modiﬁed GAL1 promoters can increase induced expres-
sion without increasing basal expression (i.e. in the
absence of inducer, the distribution of ﬂuorescence
intensities is indistinguishable from cells lacking GFP),
leading to an overall increase in the system’s dynamic
range.
To test the effect of 50-UTR sequence on induciblity, the
GAL1 50-UTR was removed and replaced with that of
GAL80 or SOL1 (23), both of which encode more stable
transcripts than GAL1 in glucose-grown cells (24). In
glucose, the average half-life of mRNAs in yeast is
20.1±8.6min (24). The GAL80 mRNA half-life is
27min and that of SOL1 is 79min, whereas the half-life
of GAL1 mRNA is 19min (24). Despite GAL80 and SOL1
being more stable transcripts, we ﬁnd their 50-UTR
sequence to be slightly deleterious to overall protein pro-
duction in the context of the modiﬁed GAL1 promoter
(Figure 2B, P5 and P6).
Altering promoter context and binding site copy number
Different numbers of Zif268 binding sites were placed
upstream of a 249-bp crippled CYC1 promoter sequence
from (25). From these experiments, we ﬁnd that that at
both 10 nM and 1 mM b-estradiol, induction correlates
with binding site copy number (Figure 3A). One binding
site is sufﬁcient to make the promoter inducible (Figure
BUD9 Locus gfpura3hER vp16zif268
+ Inducer
variable promoter region
 ACGGCCGGCCAAGCACGCGGGGAT
TTTGCCGCCCAAAGAGCCGAACGAACTACCTTAACA
Figure 1. Schematic of BUD9 locus in engineered yeast strains. Universal primer sites (shown in green and blue) ﬂank the variable promoter region
in all strains. Gene terminators are represented by ‘T’ in the ﬁgure. The ENO2 terminator follows Z3EV and the GAL80 terminator follows GFP.
The promoter/terminator pair surrounding URA3 is the same as the native gene.
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3A, P7). Unlike in the case of the modiﬁed GAL1 pro-
moters, increased induction comes at the cost of increased
basal expression in the absence of inducer (the basal ex-
pression from the promoter with eight binding sites is 6-
fold greater than that with a single binding site). While
going from 4 to 8 binding sites results in a 17% increase in
GFP expression at 1 mM b-estradiol, the basal expression
doubles. This results in the fold-change of induction being
non-monotonic with respect to binding site copy number
(Figure 3B).
Increasing the number of promoter chassis
Based on the aforementioned results, it seemed reason-
able that other promoters could be made inducible as
well. DAN1, HOP1 and HOP2 are strongly repressed
in asexually grown yeast. DAN1 encodes a cell wall
mannoprotein that is expressed under anaerobic condi-
tions (26,27). HOP1 and HOP2 gene products are
both involved in the regulation of meiosis (28,29).
Whereas a DAN1 promoter containing Zif268
binding sequences was made inducible by b-estradiol
(Figure 4, P13), the modiﬁed HOP1 and HOP2 pro-
moters were not (Figure 4, P11 and P12). ‘CYC1
Minimal’ promoters (CM1 and CM2), whose expres-
sion was attenuated based on results from Guarente
and colleagues (30), were also made strongly inducible
by the addition of Zif268 binding sites (Figure 4, P14
and P15).
Table 1. List of yeast strains used in experiments
Strain Genotype Source
DBY12000 GAL2+ s288c with repaired HAP1 allele (8)
DBY19000 ura3D::NatMX This study
DBY19004 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-Z3EVpr(P1)-GFP-Gal80term This study
DBY19017 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-CM2pr(P15)-GFP-Gal80term This study
DBY19018 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-HOP2pr(P12)-GFP-Gal80term This study
DBY19019 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-HOP1pr(P11)-GFP-Gal80term This study
DBY19050 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-CM1pr(P14)-GFP-Gal80term This study
DBY19052 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-Z3EVpr(P2)-GFP-Gal80term This study
DBY19053 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-Z3EVpr(P3)-GFP-Gal80term This study
DBY19054 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-Z3EVpr(P4)-GFP-Gal80term This study
DBY19055 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-Z3EVpr(P6)-GFP-Gal80term This study
DBY19056 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-Z3EVpr(P5)-GFP-Gal80term This study
DBY19058 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-CrippledCYC1pr(P7)-GFP-Gal80term This study
DBY19059 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-CrippledCYC1pr(P8)-GFP-Gal80term This study
DBY19061 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-CrippledCYC1pr(P9)-GFP-Gal80term This study
DBY19063 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-CrippledCYC1pr(P10)-GFP-Gal80term This study
DBY19065 ura3D::NatMX, bud9::ACT1pr-Z3EV-ENO2term-URA3-DAN1pr(P13)-GFP-Gal80term This study
DBY19068 ura3D::NatMX, bud9::CYC1pr-Z3E(4S)V-YPR052Cterm -URA3-Z3EVpr(P1)-GFP-Gal80term This study
DBY19070 ura3D::NatMX, bud9::ACT1pr-Z3E(4S)V-YPR052Cterm-URA3-Z3EVpr(P1)-GFP-Gal80term This study
All 19 000 series yeast strains are in the CEN-PK113-7d background. In the genotypes, ‘pr’ indicates a promoter and ‘term’ indicates a terminator.
Z3EVpr indicates a modiﬁed version of the GAL1 promoter that contains Zif268 binding sites. All Z3EV-responsive promoters have a unique number
(P1, P2, . . . , P15).
No Inducer
10 nM
1 µM
 0            5000        10000       15000       20000
No GFP
6x
5x
6x
6x
GAL1 promoter 
A B No GFP
GAL1 5’UTR (P1)
SOL1 5’UTR (P5)
GAL80 5’UTR (P6)
No Inducer
10 nM
1 µM
0               2000          4000           6000           8000
Zif268 Binding Site
P1
P2
P3
P4
GFP 
Figure 2. Engineered GAL1 promoter variants. (A) Measuring the effects of Zif268 binding site location and spacing on Z3EV-mediated gene
induction. Schematic cartoons (not drawn to scale) illustrate the tested promoter architectures and bar plots are measurements of GFP intensity
in the presence or absence of inducer following 12 h of induction. (B) Measuring the effects of 50-UTR sequence on Z3EV-mediated gene induction,
by replacing the GAL1 50-UTR with that of SOL1 or GAL80. Error bars represent the standard deviation of ﬂuorescence from three independent
colonies/cultures.
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Changing the ligand speciﬁcity of Z3EV
After ﬁnding that Z3EV-responsive promoters could be en-
gineered in a straightforward fashion, we wanted to see if
they could be made to respond to a non-hormone small
molecule. It has previously been demonstrated that ligand
speciﬁcity of hER can be altered through directed evolu-
tion using two-hybrid screening in yeast (31–34). Indeed,
mutant estrogen receptors have been engineered with
enhanced speciﬁcity for resveratrol-like compounds (33),
androgens (34), and synthetic small molecules, including
DHB and 2,4-di(4-hydroxyphenyl)-5-ethylthiazole (L9)
(31,32). Based on results from (31), we synthesized a
codon-optimized variant of Z3EV, called Z3E(4S)V, that
contains ﬁve hER domain amino acid substitutions. Z3EV
and Z3E(4S)V contain amino acids 282–576 of the alpha
subunit of the hER. According to this numbering,
Z3E(4S)V contains the hER substitutions L346I,
A350M, M388Q, G521S and Y526D.
We ﬁnd that the wild-type Z3EV construct is non-re-
sponsive with respect to the small molecule DHB at or
below concentrations of 1 mM (Figure 5). Z3E(4S)V is
 0            2000         4000         6000         8000
No GFP No Inducer
10 nM
1 µM1x
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4x
8x
Crippled 
CYC1 promoter 
A B
Zif268 Binding Site
Fo
ld
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ng
e
4
8
12
Binding site copy number
1                  3                  4                   8
P7
P8
P9
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GFP
Figure 3. The effect of Zif268 binding site copy number on expression in crippled CYC1 promoters. (A) Measuring the effect of Zif268 binding site
copy number on basal and induced expression when placed directly upstream of the crippled CYC1 promoter from (25). (B) The fold-change of
expression at 1 mM b-estradiol over uninduced cells as a function of binding site copy number. Error bars represent the standard deviation of
ﬂuorescence from three independent colonies/cultures.
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Figure 5. Dose–response curves for wild-type and mutant Z3EV
variants. Responses to b-estradiol and DHB (short-dashes and solid
lines, respectively) are shown for Z3EV (top) and Z3E(4S)V (bottom).
A horizontal line (long dashes) indicates a 2-fold change in expression
of GFP in each plot. Gray shading indicates concentrations of DHB to
which Z3EV is not activated (top) or concentrations of b-estradiol to
which Z3E(4S)V is not activated (bottom). Fluorescence measurements
were made using ﬂow cytometry.
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Figure 4. Testing the ability of alternative promoter chassis to be made
inducible. Data are shown for six different promoters, including our
initial modiﬁed GAL1 promoter design (P1). CM1 and CM2 are two
different variants of ‘CYC1 Minimal’ promoters we designed to remove
basal activity from the wild-type CYC1 promoter. Error bars represent
the standard deviation of ﬂuorescence from three independent colonies/
cultures.
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induced by 100 nM DHB, but is non-responsive to any of
the tested concentrations of b-estradiol. For both Z3EV
and Z3E(4S)V, the response to inducer is graded and the
coefﬁcient of variation in GFP intensities remains nearly
unchanged in induced cells (i.e. the shape of the distribu-
tion of expression intensities remains unchanged)
(Supplementary Figure S1). Altering the ligand speciﬁcity
did, however, increase the leakiness of Z3E(4S)V over the
original Z3EV construct in the absence of inducer during
log-phase growth (Supplementary Figure S2). The leaki-
ness was reduced by decreasing the promoter strength
driving Z3E(4S)V, but it is not clear from our results if
this problem is completely avoidable. Changing ligand
speciﬁcity does not affect the time it takes to see induction
of GFP (Supplementary Figure S2), and similar to b-es-
tradiol, DHB has no measured effect on gene expression
(Figure 6A and B) or growth (Figure 6C).
DISCUSSION
The presented experiments sought to identify basic design
principles for engineering Z3EV-responsive promoters,
develop and characterize a toolkit for making their imple-
mentation straightforward and illustrate that the ligand
speciﬁcity of Z3EV can be altered to respond to a non-
hormone small molecule. As S. cerevisiae is important in
both basic and applied research, these tools have many
potential applications, such as engineering orthogonal
pathways into yeast for making target molecules: the
fact the Z3EV system is titratible should enable facile
testing of the relationship between target gene expression
levels and product yield. We envision that the different
strength promoters developed here will enable simultan-
eous expression of multiple gene products to different
levels in the presence of a single concentration of
inducer, making them effective tools for metabolic engin-
eering and pathway optimization.
Finding cheaper non-hormone ligands
While inert with respect to yeast physiology, the use of
hormone-based genetic switches is limited to academic
or small- to moderate-scale experiments due to their po-
tential for negatively impacting the environment. Only a
handful of mutations are required for making a Z3EV
variant that is strongly activated in the presence of a
non-hormone small molecule, DHB; this molecule,
however, is quite expensive, costing $2000/g to synthe-
size commercially. A less soluble, cheaper DHB-like
molecule in which the hydroxyl groups are replaced with
methyl groups failed to induce Z3E(4S)V (data not
shown). To make Z3EV a system that can be used at in-
dustrial scales, variants need to be engineered that respond
not just to any non-hormone small molecules, but to ones
that are (i) cheap to synthesize in large quantities and (ii)
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Figure 6. DHB has no effect on gene expression or growth. 1 mM DHB was introduced to phosphate-limited chemostat culture of strain DBY12000
at steady state. Samples were harvested at t=0, 30, 180 and 360min following DHB addition. (A) Hierarchical clustering of global gene expression
response to DHB. Data are normalized to the t=0 sample. (B) Data from (A) represented as a box plot. (C) DBY12000 grown in the presence of
different amounts of DHB.
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retain high speciﬁcity for the mutant receptor. Such
mutant receptors may be identiﬁable using the previously
published yeast two-hybrid approach (34), or perhaps a
new selection scheme using the Z3EV system.
Increasing sequence diversity
DNA assembly methods facilitate stitching large numbers
of individual DNA ‘parts’ to form larger DNA assemblies.
Generating these assemblies through gap-repair cloning in
yeast (35) can facilitate engineering biochemical pathways
(36) as well as entire genomes (37) on a single plasmid.
However, all DNA assembly methods require sufﬁcient
DNA sequence diversity for parts to be properly
assembled (large stretches of degenerate sequences in-
creases the number of statistically likely assemblies).
In this manuscript, we identiﬁed several different
promoter chassis that can be made inducible. Therefore,
if one wants to assemble a pathway in which each gene is
inducible to different levels (and is expressed at different
basal levels), the promoters we identiﬁed can be readily
used. In the case where more than a handful of genes
require unique basal/induced expression levels, it may be
necessary to ﬁnd additional promoter chassis, whose basal
expression can be predicted via publicly available gene
expression microarray data sets. Promoters that are re-
pressed during asexual growth (such as HOP1 and
HOP2) may not become inducible simply by adding
Zif268 binding sites, which we anticipate is due to the
presence of strong repressor elements; however, we have
not completely ruled out the possibility that such pro-
moters could become inducible with (i) additional Zif268
binding sites and/or (ii) Zif268 binding sites in different
locations.
Conclusion
We have presented synthetic biology tools that enable
dynamic perturbation of gene expression levels in
S. cerevisiae using the ATF Z3EV. We demonstrate that
the ligand speciﬁcity of Z3EV can be readily re-
programmed using just a handful of amino acid substitu-
tions in the hER domain. In contrast to other published
methods, these tools can be immediately applied to cells
growing under diverse physiological conditions without
otherwise perturbing the cellular physiology.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We would like to acknowledge support provided by the
Automated Strain Engineering group and Lab Services
team at Amyris, Inc. We thank Chris Paddon, Tim
Geistlinger, and Xin Wang for many lively discussions,
David Pincus for providing the crippled CYC1 promoter
sequence, and ﬁnally, Zhongxia Wang and Yuzhong
Wang for their hospitality while this paper was being
written.
FUNDING
National Institutes of Health grant [GM046406 to D.B.];
NIGMS Center for Quantitative Biology grant
[GM071508 to D.B.]. Funding for open access charge:
National Institutes of Health grant [GM046406 to D.B.].
Conﬂict of interest statement. P.A. Gibney, S.S. Chandran,
and K.R. Benjamin own shares of Amyris, Inc. D.
Botstein is a member of the Scientiﬁc Advisory Board
for Amyris, Inc.
REFERENCES
1. Raveh-Sadka,T., Levo,M., Shabi,U., Shany,B., Keren,L., Lotan-
Pompan,M., Zeevi,D., Sharon,E., Weinberger,A. and Segal,E.
(2012) Manipulating nucleosome disfavoring sequences allows
ﬁne-tune regulation of gene expression in yeast. Nat. Genet., 44,
743–750.
2. Khalil,A.S., Lu,T.K., Bashor,C.J., Ramirez,C.L., Pyenson,N.C.,
Joung,J.K. and Collins,J.J. (2012) A synthetic biology framework
for programming eukaryotic transcription functions. Cell, 150,
647–658.
3. McIsaac,R.S., Oakes,B.L., Wang,X., Dummit,K.A., Botstein,D.
and Noyes,M.B. (2013) Synthetic gene expression perturbation
systems with rapid, tunable, single-gene speciﬁcity in yeast.
Nucleic Acids Res., 41, e57.
4. Sharon,E., Kalma,Y., Sharp,A., Raveh-Sadka,T., Levo,M.,
Zeevi,D., Keren,L., Yakhini,Z., Weinberger,A. and Segal,E.
(2012) Inferring gene regulatory logic from high-throughput
measurements of thousands of systematically designed promoters.
Nat. Biotechnol., 30, 521–530.
5. Blount,B.A., Weenink,T., Vasylechko,S. and Ellis,T. (2012)
Rational diversiﬁcation of a promoter providing ﬁne-tuned
expression and orthogonal regulation for synthetic biology. PLoS
One, 7, e33279.
6. Dvir,S., Velten,L., Sharon,E., Zeevi,D., Carey,L.B., Weinberger,A.
and Segal,E. (2013) Deciphering the rules by which 50-UTR
sequences affect protein expression in yeast. Proc. Natl Acad. Sci.
USA, 110, E2792–E2801.
7. Shalem,O., Carey,L., Zeevi,D., Sharon,E., Keren,L.,
Weinberger,A., Dahan,O., Pilpel,Y. and Segal,E. (2013)
Measurements of the impact of 30 end sequences on gene
expression reveal wide range and sequence dependent effects.
PLoS Comput. Biol., 9, e1002934.
8. Hickman,M.J., Petti,A.A., Ho-Shing,O., Silverman,S.J.,
McIsaac,R.S., Lee,T.A. and Botstein,D. (2011) Coordinated
regulation of sulfur and phospholipid metabolism reﬂects the
importance of methylation in the growth of yeast. Mol. Biol. Cell,
22, 4192–4204.
9. McIsaac,R.S., Petti,A.A., Bussemaker,H.J. and Botstein,D. (2012)
Perturbation-based analysis and modeling of combinatorial
regulation in the yeast sulfur assimilation pathway. Mol. Biol.
Cell, 23, 2993–3007.
10. Douglas,A.C., Smith,A.M., Sharifpoor,S., Yan,Z., Durbic,T.,
Heisler,L.E., Lee,A.Y., Ryan,O., Gottert,H., Surendra,A. et al.
(2012) Functional analysis with a barcoder yeast gene
overexpression system. G3, 2, 1279–1289.
11. Labbe,S. and Thiele,D.J. (1999) Copper ion inducible and
repressible promoter systems in yeast. Methods Enzymol., 306,
145–153.
12. Hovland,P., Flick,J., Johnston,M. and Sclafani,R.A. (1989)
Galactose as a gratuitous inducer of GAL gene expression in
yeasts growing on glucose. Gene, 83, 57–64.
13. Belli,G., Gari,E., Piedraﬁta,L., Aldea,M. and Herrero,E. (1998)
An activator/repressor dual system allows tight tetracycline-
regulated gene expression in budding yeast. Nucleic Acids Res.,
26, 942–947.
14. Louvion,J.F., Havaux-Copf,B. and Picard,D. (1993) Fusion of
GAL4-VP16 to a steroid-binding domain provides a tool for
gratuitous induction of galactose-responsive genes in yeast. Gene,
131, 129–134.
Nucleic Acids Research, 2014 7
 at California Institute of Technology on January 27, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
15. McIsaac,R.S., Silverman,S.J., McClean,M.N., Gibney,P.A.,
Macinskas,J., Hickman,M.J., Petti,A.A. and Botstein,D. (2011)
Fast-acting and nearly gratuitous induction of gene expression
and protein depletion in Saccharomyces cerevisiae. Mol. Biol. Cell,
22, 4447–4459.
16. Fliss,A.E., Benzeno,S., Rao,J. and Caplan,A.J. (2000) Control of
estrogen receptor ligand binding by Hsp90. J. Steroid Biochem.
Mol. Biol., 72, 223–230.
17. Takahashi,S. and Pryciak,P.M. (2008) Membrane localization of
scaffold proteins promotes graded signaling in the yeast MAP
kinase cascade. Curr. Biol., 18, 1184–1191.
18. McIsaac,R.S., Oakes,B.L., Botstein,D. and Noyes,M.B. (2013)
Rapid synthesis and screening of chemically activated
transcription factors with GFP-based reporters. J. Vis. Exp., 81,
e51153.
19. Nijkamp,J.F., van den Broek,M., Datema,E., de Kok,S.,
Bosman,L., Luttik,M.A., Daran-Lapujade,P., Vongsangnak,W.,
Nielsen,J., Heijne,W.H. et al. (2012) De novo sequencing,
assembly and analysis of the genome of the laboratory
strain Saccharomyces cerevisiae CEN.PK113-7D, a model
for modern industrial biotechnology. Microb. Cell Fact.,
11, 36.
20. Gietz,R.D. and Woods,R.A. (2002) Transformation of yeast by
lithium acetate/single-stranded carrier DNA/polyethylene glycol
method. Methods Enzymol., 350, 87–96.
21. Dharmadi,Y., Patel,K., Shapland,E., Hollis,D., Slaby,T.,
Klinkner,N., Dean,J. and Chandran,S.S. (2013) High-throughput,
cost-effective veriﬁcation of structural DNA assembly. Nucleic
Acids Res., November 6 (doi: 10.1093/nar/gkt1088; epub ahead of
print).
22. Brauer,M.J., Huttenhower,C., Airoldi,E.M., Rosenstein,R.,
Matese,J.C., Gresham,D., Boer,V.M., Troyanskaya,O.G. and
Botstein,D. (2008) Coordination of growth rate, cell cycle, stress
response, and metabolic activity in yeast. Mol. Biol. Cell, 19,
352–367.
23. Nagalakshmi,U., Wang,Z., Waern,K., Shou,C., Raha,D.,
Gerstein,M. and Snyder,M. (2008) The transcriptional landscape
of the yeast genome deﬁned by RNA sequencing. Science, 320,
1344–1349.
24. Munchel,S.E., Shultzaberger,R.K., Takizawa,N. and Weis,K.
(2011) Dynamic proﬁling of mRNA turnover reveals gene-speciﬁc
and system-wide regulation of mRNA decay. Mol. Biol. Cell, 22,
2787–2795.
25. Brandman,O., Stewart-Ornstein,J., Wong,D., Larson,A.,
Williams,C.C., Li,G.W., Zhou,S., King,D., Shen,P.S.,
Weibezahn,J. et al. (2012) A ribosome-bound quality control
complex triggers degradation of nascent peptides and signals
translation stress. Cell, 151, 1042–1054.
26. Mrsa,V., Ecker,M., Strahl-Bolsinger,S., Nimtz,M., Lehle,L. and
Tanner,W. (1999) Deletion of new covalently linked cell wall
glycoproteins alters the electrophoretic mobility of phosphorylated
wall components of Saccharomyces cerevisiae. J. Bacteriol., 181,
3076–3086.
27. Sertil,O., Cohen,B.D., Davies,K.J. and Lowry,C.V. (1997) The
DAN1 gene of S. cerevisiae is regulated in parallel with the
hypoxic genes, but by a different mechanism. Gene, 192, 199–205.
28. Hollingsworth,N.M. and Byers,B. (1989) HOP1: a yeast meiotic
pairing gene. Genetics, 121, 445–462.
29. Leu,J.Y., Chua,P.R. and Roeder,G.S. (1998) The meiosis-speciﬁc
Hop2 protein of S. cerevisiae ensures synapsis between
homologous chromosomes. Cell, 94, 375–386.
30. Guarente,L., Lalonde,B., Gifford,P. and Alani,E. (1984)
Distinctly regulated tandem upstream activation sites mediate
catabolite repression of the CYC1 gene of S. cerevisiae. Cell, 36,
503–511.
31. Chockalingam,K., Chen,Z., Katzenellenbogen,J.A. and Zhao,H.
(2005) Directed evolution of speciﬁc receptor-ligand pairs for use
in the creation of gene switches. Proc. Natl Acad. Sci. USA, 102,
5691–5696.
32. McLachlan,M.J., Chockalingam,K., Lai,K.C. and Zhao,H. (2009)
Directed evolution of orthogonal ligand speciﬁcity in a single
scaffold. Angew. Chem. Int. Ed. Engl., 48, 7783–7786.
33. Islam,K.M., Dilcher,M., Thurow,C., Vock,C., Krimmelbein,I.K.,
Tietze,L.F., Gonzalez,V., Zhao,H. and Gatz,C. (2009) Directed
evolution of estrogen receptor proteins with altered ligand-binding
speciﬁcities. Protein Eng. Des. Sel., 22, 45–52.
34. Chen,Z., Katzenellenbogen,B.S., Katzenellenbogen,J.A. and
Zhao,H. (2004) Directed evolution of human estrogen receptor
variants with signiﬁcantly enhanced androgen speciﬁcity and
afﬁnity. J. Biol. Chem., 279, 33855–33864.
35. Ma,H., Kunes,S., Schatz,P.J. and Botstein,D. (1987) Plasmid
construction by homologous recombination in yeast. Gene, 58,
201–216.
36. Shao,Z., Zhao,H. and Zhao,H. (2009) DNA assembler, an in vivo
genetic method for rapid construction of biochemical pathways.
Nucleic Acids Res., 37, e16.
37. Gibson,D.G., Benders,G.A., Axelrod,K.C., Zaveri,J., Algire,M.A.,
Moodie,M., Montague,M.G., Venter,J.C., Smith,H.O. and
Hutchison,C.A. III (2008) One-step assembly in yeast of 25
overlapping DNA fragments to form a complete synthetic
Mycoplasma genitalium genome. Proc. Natl Acad. Sci. USA, 105,
20404–20409.
8 Nucleic Acids Research, 2014
 at California Institute of Technology on January 27, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
